News The latest developments in autism research.
Profiles Portraits of scientists who are making a mark on autism research.
Toolbox Emerging tools and techniques that may advance autism research.
Spotted A roundup of autism papers and media mentions you may have missed.
Opinion Conversations on the science of autism research.
Viewpoint Expert opinions on trends and controversies in autism research.
Columnists Dispatches from experts on various facets of autism.
Crosstalk Debates and conversations about timely topics in autism.
Reviews Exploring the intersection of autism and the arts.
Q&A Conversations with experts about noteworthy topics in autism.
Deep Dive In-depth analysis of important topics in autism.
Special Reports Curated collections of articles on special topics in autism.
Webinars Presentations by leading experts on their latest research.
News / Spotted

Injury risk; stem-cell start; food faces

by  /  9 June 2017

WEEK OF
June 5th

Injury risk

Compared with the general population, people who have autism are at much greater risk of death from injury, with the largest risks coming from suffocation, asphyxiation and drowning. A study published last week in the American Journal of Public Health also found that the average age of people with autism at death is just about half that of the general population, at 36.2 versus 72 years. Earlier research also has shown a greater risk of premature death among people with autism

Sources
American Journal of Public Health / 01 May 2017

Injury mortality in individuals with autism

Nonviolent findings

Having autism alone isn’t associated with committing violent crime, according to research published this week in the Journal of the American Academy of Child & Adolescent Psychiatry. The researchers looked at violent crime convictions among 295,734 teenagers and young adults in Stockholm County, Sweden, of whom 5,739 had an autism diagnosis. Earlier findings had hinted at a link between violent offending and autism, but the individuals with autism who did not have co-occurring conditions had no greater odds of violent offending than did people in the general population.

More than a quarter — 28 percent — of people with autism in this study had another condition, such as attention deficit hyperactivity disorder, conduct disorder or substance abuse, that did increase the chances of committing a violent offense.

Sources
Journal of the American Academy of Child & Adolescent Psychiatry / 01 Jun 2017

Autism and convictions for violent crimes: Population-based cohort study in Sweden

Genetic dosing

Chromosome 22q11.2 duplications are associated with both autism and differences in brain structure in brain scans, researchers reported last week in the Journal of Neuroscience. Children with 22q11.2 duplications have larger-than-average brains with thinner gray matter. Adding to growing evidence of autism and schizophrenia as ‘yin-yang’ conditions, children with 22q11.2 deletions, which are associated with increased schizophrenia risk, have unusually small brains with thicker gray matter.

Sources
Journal of Neuroscience / 26 May 2017

Mapping 22q11.2 gene dosage effects on brain morphometry

Requiring reproducibility

Editors at the Nature Publishing Group have announced additions to a checklist researchers must complete when submitting a manuscript to Nature research journals. The editors say that the additions support their goal of facilitating reproducibility in science. Researchers will have to give greater detail about their experimental designs and analyses. The editors also plan to ask researchers to avoid using bar graphs and instead to use visualizations that show full data distributions.

With each published paper, Nature journals will publish a summary containing the additional details, bringing even more transparency to the sausage-making of science. In keeping with this openness, the editors have made the templates for reporting the required information available for any journal or institution to use under a Creative Commons license.

Under threat

Science is under threat on both sides of the Atlantic, but political attitudes in the United Kingdom are a mixture of supportive and worrying, according to an editorial in Nature last week. The major U.K. political parties have pledged to back scientific research to varying degrees, yet the specter of Brexit threatens the interactive, multinational ties that have connected U.K. and E.U. researchers for decades. That threat likely pales with what U.S. scientists face, manifested in part in Trump’s proposed budget, which calls for deep cuts across science agencies. The only bright spot for U.S. scientists is that the budget is probably a nonstarter in Congress.

In the face of these budget-cut threats, Francis Collins will stay on as director of the National Institutes of Health (NIH), the White House announced Tuesday. Collins became director in 2009 and has overseen major NIH programs, including former President Barack Obama’s BRAIN Initiative. The initiative, Collins wrote on his director’s blog, is expected to “revolutionize neuroscience” and help “millions of people,” including those with autism.

Sources
Nature / 31 May 2017

Keep shouting to save science

Stem-cell start

China is set to start its first clinical trials involving human embryonic stem cells — in this case, for Parkinson’s disease. Researchers plan to prod the cells to form immature neurons and to inject several million of them into the brain. Researchers in Australia began a stem-cell trial for Parkinson’s last year, but they derived their cells from unfertilized eggs coaxed into embryonic development. In neither study, however, are the cells fully formed dopamine-producing cells, which has raised concerns, according to a report in Nature, because their fate is difficult to predict.

International Stem Cell Corporation, the California-based supplier for the Australian team, reports that 97 percent of the stem cells do mature into neurons that release dopamine. Researchers in China also plan to conduct a similar trial for age-related macular degeneration. U.S. scientists have used the cells to grow brains in a dish, or ‘mini-brains,’ as a neuroscience tool.

RDoC resource

Joshua Gordon, who took over as director of the National Institute of Mental Health last summer, has announced the launch of a big-data resource. The goal of the All of Us Research Program is to enroll a million-plus volunteers who will make their personal medical data available. Of these, about 100,000 individuals would supply data about psychiatric conditions. Participants will also complete surveys and provide tissue samples for research. This huge repository is expected to be a goldmine for researchers interested in how lifestyle and environment influence our biology.

Sources
National Institute of Mental Health / 05 Jun 2017

The future of RDoC

Food faces

People with autism may have problems recognizing faces. A new study in Scientific Reports suggests this difficulty extends to faces formed from food. Marina Pavlova and her colleagues previously used their Face-n-Food images to compare sex-based differences in facial recognition. Now they report that when people with autism view faces created from foods in the style of 16th century Italian painter Giuseppe Arcimboldo, they are less likely than controls to see faces in the arrangements.

Women are generally better than men at detecting the faces in the food designs, but whether this is true among people with autism is not known: The autism group in the new study included only one girl. In another paper, published last year in Frontiers in Psychology, the researchers found that people with Williams syndrome also have difficulty seeing the faces in food images.

Sources
Scientific Reports / 26 May 2017

Social cognition in autism: Face tuning

Sources
Frontiers in Psychology / 02 Aug 2016

Social cognition in Williams syndrome: Face tuning

Seizure cells

A region in the middle of the brain called the reticular thalamus contains two types of neurons that could link seizure activity and conditions such as autism. The new findings, published Tuesday in Cell Reports, suggest that one cell type might be a therapeutic target for seizures. The other kind of neuron seems to play a role in schizophrenia and attention deficit hyperactivity disorder.

Like a 1950s switchboard operator, the job of the reticular thalamus is to direct signals to the appropriate regions on the brain’s surface, says lead researcher Jeanne Paz of the Gladstone Institutes in San Francisco, California. The region has roles in attention, consciousness and perception, as well as seizures. In this work in mice, the team used optogenetics — the use of light to activate cells containing light-sensitive proteins — to distinguish the two cell types.

Paz said in a statement that interactions between the two types might explain why seizures often co-occur with conditions such as schizophrenia and autism.

Data rules

The International Committee of Medical Journal Editors has established new requirements for manuscript submissions. In a statement published 5 June in a dozen journals, including the Journal of the American Medical Association, the New England Journal of Medicine, the British Medical Journal and The Lancet, the committee instructs researchers to provide a data-sharing statement for any manuscripts submitted to member journals, starting 1 July 2018. The statements must specify which data will be shared, when the data will be available, and who can access them and how. In addition, all clinical trials that enroll starting on or after 1 January 2019 must add a data-sharing plan as part of the trial’s registration.

Prestigious prize

Brain science titan Karl Deisseroth of Stanford University in California has received the 4 million euro Fresenius Prize, one of science’s “most generous” awards, the U.S. National Institute of Mental Health announced last week. He earned the honor through his work on three exciting fronts in neuroscience: optogenetics, the CLARITY technique of brain visualization and a method for viewing brain circuits in real time in rats. The Else Kröner-Fresenius Foundation awards the prize every four years. This year’s focus was on mid-career scientists whose work addresses the biology of psychiatric conditions. Deisseroth gets to keep half a million euros for himself and devote the rest to his lab’s research.

Sources
National Institute of Mental Health / 31 May 2017

NIMH grantee wins one of science’s most coveted prizes

Job news

Making a career move? Send your news to [email protected].


close

Log in to your Spectrum Wiki account

Email Address:

Password:


close

Request your Spectrum Wiki account

Spectrum Wiki is a community of researchers affiliated with an academic or research institutions. To be considered for participation, please fill out this form and a member of our team will respond to your request.

Name:

Email Address:

Title and Lab:

Area of Expertise:

Comments: